Bio Essence acquires MediFlow AI software for $3.5M in stock; closes share assignments to three individuals

Bio Essence Corp

Acquired MediFlow AI (formerly AcuVital) from Zhituo Software for $3,500,000 in restricted common stock.
Board approved issuance of 7,000,000 shares at $0.50/share based on five-day trading average.
Shares assigned to three Zhituo principals: Dangwei Zhu (3.5M), Jiahui Zhang (1.75M), Xiaoquiang Cai (1.75M).
Assignments executed May 9, 2026; share issuances deemed effective May 19, 2026, closing the deal.
No prior material relationship existed between Bio Essence and Zhituo or the assignees.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.